Sun Pharma Establishes Endowed Professorship at Mount Sinai
News related to:Sun Pharma · 2 min read
MUMBAI, India and PRINCETON, N.J., Oct. 6, 2026 /CourierPR/ -- Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company, has established the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai. The professorship, supported by a $2.5 million endowment from Sun Pharma, will fund academic leadership in dermatology in perpetuity, beginning with Mark G. Lebwohl, M.D., as the inaugural professor.
Lebwohl, who serves as Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology, will hold the position. His appointment reflects his extensive contributions to the field, including his role as Chairman Emeritus of the Medical Board of the National Psoriasis Foundation and his presidency of the American Academy of Dermatology from 2015 to 2016.
The professorship, based within the Kimberly and Eric J. Waldman Department of Dermatology, aims to advance research and training, translating emerging knowledge into better patient care and preparing future leaders in the field. Sun Pharma, the second-largest pharmaceutical dermatology company in the U.S. by prescription volume, is committed to advancing patient care through scientific innovation, education, and partnerships.
Dr. Lebwohl's influence on dermatology is evident in his contributions to research and clinical care, as well as in the many physicians and investigators he has guided throughout his career. His work has helped advance understanding of inflammatory skin diseases and shaped standards of care that have improved patient outcomes worldwide.
Sun Pharma, a recognized leader in dermatology, is committed to advancing care through scientific innovation, education, and partnerships. The company's Global Innovative Medicines portfolio, which spans innovative products in dermatology, ophthalmology, and oncodermatology, accounts for about 22% of its company sales. Its vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. The company's multi-cultural workforce is drawn from over 50 nations, reflecting its global reach and commitment to diversity.
The Sun Professorship in Dermatology is a fitting recognition of Dr. Lebwohl's impact on the field and will help sustain the momentum of scientific advancement in dermatology.